Two cases of anaphylaxis due to contrast media during administration of nivolumab and ipilimumab in metastatic renal cell carcinoma

Kunihisa Nezu1, Hiromichi Katayama2, Atsushi Kyan2
1Department of Urology, Shirakawa Kousei General Hospital, 2-1, Kamiyazirou, Toyochi, Shirakawa, 961 0005 Fukushima Japan.
2Department of Urology, Shirakawa Kousei General Hospital, Shirakawa, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Motzer RJ, Escudier B, McDermott DF et al (2015) Nivolumab versus everolimus in advanced renal-cell carcinoma. N Engl J Med 373:1803–1813

Motzer RJ, Tannir NM, McDermott DF et al (2018) Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma. N Engl J Med 378:1277–1290

Brockow K, Christiansen C, Kanny G et al (2005) Management of hypersensitivity reactions to iodinated contrast media. Allergy 60:150–158

Ridolfi L, De Rosa F, Petracci E et al (2018) Increased frequency of acute reactions to iodinated contrast media in cancer patients treated with anti-CTLA-4 immunomodulatory antibodies. Med Hypotheses 119:26–28

Martins F, Sofiya L, Sykiotis GP et al (2019) Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nat Rev Clin Oncol. https://doi.org/10.1038/s41571-019-0218-0

Rosskopf S, Jahn-Schmid B, Schmetterer KG et al (2018) PD-1 has a unique capacity to inhibit allergen-specific human CD4(+) T cell responses. Sci Rep 8(1):13543

Saidova A, Hershkop AM, Ponce M et al (2018) Allergen-specific T cells in IgE-mediated food allergy. Archivum Immunologiae et Therapiae Experimentalis 66:161–170

Buchbinder EI, Desai A (2016) CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition. Am J Clin Oncol 39(1):98–106

Sakata Y, Kawamura K, Ichikado K et al (2019) The association between tumor burden and severe immune-related adverse events in non-small cell lung cancer patients responding to immune-checkpoint inhibitor treatment. Lung Cancer 130:159–161

Simons FER, Ardusso LRF, Bilò MB et al (2011) World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J 4:13–37

Tschiedel E, Assert R, Felderhoff-Muser U et al (2018) Undue elevation of procalcitonin in pediatric paracetamol intoxication is not explained by liver cell injury alone. Ann Hepatol 17:631–637

Chang A, Robison R, Cai M, et al (2016) Natural history of food-triggered atopic dermatitis and development of immediate reactions in children. J Allergy Clin Immunol Pract 4:229–236